Literature DB >> 32301958

The Promise and Peril of Antibody Testing for COVID-19.

Jennifer Abbasi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32301958     DOI: 10.1001/jama.2020.6170

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  73 in total

Review 1.  Biological characteristics and biomarkers of novel SARS-CoV-2 facilitated rapid development and implementation of diagnostic tools and surveillance measures.

Authors:  Gajanan Sampatrao Ghodake; Surendra Krushna Shinde; Avinash Ashok Kadam; Rijuta Ganesh Saratale; Ganesh Dattatraya Saratale; Asad Syed; Abdallah M Elgorban; Najat Marraiki; Dae-Young Kim
Journal:  Biosens Bioelectron       Date:  2021-01-04       Impact factor: 10.618

Review 2.  Role of Host Immune and Inflammatory Responses in COVID-19 Cases with Underlying Primary Immunodeficiency: A Review.

Authors:  Benjamin M Liu; Harry R Hill
Journal:  J Interferon Cytokine Res       Date:  2020-12       Impact factor: 2.607

3.  Correlation of the ratio of IgM/IgG concentration to days after symptom onset (IgM/T or IgG/T) with disease severity and outcome in non-critical COVID-19 patients.

Authors:  Yan Rong; Fei Wang; Xiaoli Li; Xinhua Liang; Yang Zhou; Dandan Zhang; Jing Liu; Huadong Zeng; Jing Wang; Yi Shi
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

4.  Effectiveness of infection-containment measures on SARS-CoV-2 seroprevalence and circulation from May to July 2020, in Milan, Italy.

Authors:  Valeria Cento; Claudia Alteri; Marco Merli; Federica Di Ruscio; Livia Tartaglione; Roberto Rossotti; Giovanna Travi; Marta Vecchi; Alessandro Raimondi; Alice Nava; Luna Colagrossi; Roberto Fumagalli; Nicola Ughi; Oscar Massimiliano Epis; Diana Fanti; Andrea Beretta; Filippo Galbiati; Francesco Scaglione; Chiara Vismara; Massimo Puoti; Daniela Campisi; Carlo Federico Perno
Journal:  PLoS One       Date:  2020-11-20       Impact factor: 3.240

5.  Drug Development for Mental Illness: How Psychiatry Clinical Trial Sites are Meeting the Challenge of the COVID-19 Pandemic.

Authors:  Robert E Litman; Peter Sorantin; Elia E Acevedo-Diaz
Journal:  Innov Clin Neurosci       Date:  2021-01-01

Review 6.  Review of Current COVID-19 Diagnostics and Opportunities for Further Development.

Authors:  Yan Mardian; Herman Kosasih; Muhammad Karyana; Aaron Neal; Chuen-Yen Lau
Journal:  Front Med (Lausanne)       Date:  2021-05-07

7.  SARS-COV-2 ANTIBODY PREVALENCE AMONG HEALTHCARE WORKERS AND FIRST RESPONDERS, FLORIDA, MAY-JUNE 2020.

Authors:  James Matthias; Emma C Spencer; Mara Michniewicz; Thomas M Bendle; Craig Wilson; Kenneth A Scheppke; Carina Blackmore; Aaron Otis; Scott A Rivkees
Journal:  Fla Public Health Rev       Date:  2021-02-25

8.  Rapid Point-Of-Care Serology and Clinical History Assessment Increase Protection Provided by RT-PCR Screening: A Pilot Study Involving Three Nursing Homes in Brescia, a Hotspot of Lombardy.

Authors:  Antonella Savio; Stefano Calza; Gianbattista Guerrini; Valentina Romano; Eleonora Marchina
Journal:  Front Public Health       Date:  2021-06-24

9.  COVID-19 laboratory testing issues and capacities as we transition to surveillance testing and contact tracing.

Authors:  Brendon Sen-Crowe; Mark McKenney; Adel Elkbuli
Journal:  Am J Emerg Med       Date:  2020-05-27       Impact factor: 2.469

10.  Quantification of Aerosol Particle Concentrations During Endoscopic Sinonasal Surgery in the Operating Room.

Authors:  Alex Murr; Nicholas R Lenze; William Colby Brown; Mark W Gelpi; Charles S Ebert; Brent A Senior; Brian D Thorp; Adam M Zanation; Adam J Kimple
Journal:  Am J Rhinol Allergy       Date:  2020-10-04       Impact factor: 2.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.